How will immune tolerance protocols affect self-sufficiency goals?
- PMID: 7795144
- DOI: 10.1097/00001721-199412004-00020
How will immune tolerance protocols affect self-sufficiency goals?
Abstract
Inhibitor development is a serious complication in haemophilia, and its treatment, immune tolerance therapy, is an expensive part of haemophilia treatment. However, the therapy can lead to an increased lifespan and improved quality of life. If commenced sufficiently early in the disease, it can help to reduce the overall amount of factor VIII concentrate, or other plasma derived therapeutic agents required during life.
Similar articles
-
Is haemophilia prophylaxis achievable in the context of self-sufficiency?Blood Coagul Fibrinolysis. 1994 Dec;5 Suppl 4:S71-5. doi: 10.1097/00001721-199412004-00019. Blood Coagul Fibrinolysis. 1994. PMID: 7795143
-
Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.Br J Haematol. 2013 Jan;160(2):153-70. doi: 10.1111/bjh.12091. Epub 2012 Nov 15. Br J Haematol. 2013. PMID: 23157203 No abstract available.
-
Is oral tolerance therapy possible for haemophilia with inhibitors?Vox Sang. 2001 Jan;80(1):61-2. doi: 10.1046/j.1423-0410.2001.00007.x. Vox Sang. 2001. PMID: 11339071 No abstract available.
-
The incidence of inhibitors in hemophilia A and the induction of immune tolerance.Adv Exp Med Biol. 2001;489:89-97. doi: 10.1007/978-1-4615-1277-6_8. Adv Exp Med Biol. 2001. PMID: 11554594 Review. No abstract available.
-
Inhibitors in congenital haemophilia.Baillieres Clin Haematol. 1996 Jun;9(2):319-29. doi: 10.1016/s0950-3536(96)80066-7. Baillieres Clin Haematol. 1996. PMID: 8800508 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical